Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Aivado Manuel
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Musso Alan A
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ambros Reinhard J.
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairey William
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director VON RICKENBACH JOSEF H
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Aileron Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Cunningham Timothy M.
Aileron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Aileron Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
Aileron Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Muneer A. Satter(4.9%)
Aileron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director VON RICKENBACH JOSEF H
Aileron Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Ambros Reinhard J.
Aileron Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Garner Charles
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WINDSOR JAMES BRIAN
Aileron Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-The University of Texas/Texas A&M Investment Management Company(6.2%),The Board of Regents of the University of Texas System(6.2%)
Aileron Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Muneer A. Satter(5.9%)
Aileron Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director VON RICKENBACH JOSEF H
No Data
No Data